Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr ; 121(1): 138-41, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1352543

ABSTRACT

Ursodeoxycholic acid, 10 to 20 mg/kg per day, was administered for 1 year to 22 patients with cystic fibrosis and chronic cholestasis, resulting in significantly improved liver enzyme values. However, evidence of cholestasis continued, as shown by the pattern of alkaline phosphatase isoenzymes.


Subject(s)
Cholestasis/drug therapy , Cystic Fibrosis/drug therapy , Liver/drug effects , Ursodeoxycholic Acid/therapeutic use , 5'-Nucleotidase/analysis , Adolescent , Adult , Alanine Transaminase/analysis , Alkaline Phosphatase/analysis , Aspartate Aminotransferases/analysis , Bile Acids and Salts/analysis , Bilirubin/analysis , Child , Cholestasis/enzymology , Chronic Disease , Cystic Fibrosis/enzymology , Female , Humans , Liver/enzymology , Male , gamma-Glutamyltransferase/analysis
2.
Pediatr Pulmonol ; 13(1): 22-7, 1992 May.
Article in English | MEDLINE | ID: mdl-1589308

ABSTRACT

Among the various components of tracheobronchial secretions, lipids and particularly phospholipids have been shown to influence rheological properties of airway secretions in patients with cystic fibrosis. We studied the phospholipid composition of tracheobronchial secretions, collected from patients suffering from cystic fibrosis (CF) and other chronic obstructive pulmonary diseases (COPD), and we analyzed the possible relationship between the phospholipid profile and the wettability of tracheobronchial secretions evaluated by the measurement of contact angle. Although total phospholipid content and contact angle of tracheobronchial secretions were significantly increased (P less than 0.01) in CF compared to COPD, no significant relationship existed between these two parameters. The concentrations of the different phospholipid subclasses were not homogeneously modified according to the origin of the secretions. Compared to COPD secretions, the CF secretions were characterized by a significant (P less than 0.001) increase in rigidifying fractions such as sphingomyelin and phosphatidylserine/phosphatidylinositol and a significant (P less than 0.001) decrease in surface-active fractions, such as phosphatidylcholine and phosphatidylglycerol (PG) (P less than 0.001). In the two groups, the surface-active phospholipid fraction, PG, was negatively correlated to the contact angle of tracheobronchial secretions. These results suggest that a decrease in PG content in CF secretions may be one factor responsible for an increase in their adhesivity to the respiratory mucosa, and, consequently, for mucus stasis and severity of bronchial obstruction in cystic fibrosis.


Subject(s)
Cystic Fibrosis/physiopathology , Lung Diseases, Obstructive/physiopathology , Mucus/chemistry , Mucus/physiology , Phospholipids/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Bronchiectasis/physiopathology , Child , Humans , Middle Aged , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...